Fluid markers of synapse degeneration in synucleinopathies

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653 · see citing works

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069 · see citing works

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works

Second consensus statement on the diagnosis of multiple system atrophy

Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140 · see citing works

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works

Diagnostic Criteria for Parkinson Disease

Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822 · see citing works

α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

Burré, J., Sharma, M., Tsetsenis, T., Buchman, V. L., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,817 · see citing works

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646 · see citing works

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594 · see citing works

Consensus statement on the diagnosis of multiple system atrophy

Gilman, S., Low, P. A., Quinn, N. P., Albanese, A., Ben‐Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1998) · Clinical Autonomic Research · doi:10.1007/bf02309628 · Cited by 1,316 · see citing works

Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis

Nemani, V. M., Lü, W., Berge‐Seidl, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,051 · see citing works

Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria

Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972 · see citing works

SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse

Koopmans, F., van Nierop, P., Andres-Alonso, M., Byrnes, A., Cijsouw, T., Coba, M. P., Cornelisse, L. N., Farrell, R. J., Goldschmidt, H. L., Howrigan, D. P., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.002 · Cited by 938 · see citing works

Research criteria for the diagnosis of prodromal dementia with Lewy bodies

McKeith, I. G., Ferman, T. J., Thomas, A. J., Blanc, F., Boeve, B. F., Fujishiro, H., Kantarci, K., Muscio, C., O'Brien, J. T., Postuma, R. B., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009323 · Cited by 782 · see citing works

Update of the MDS research criteria for prodromal Parkinson's disease

Heinzel, S., Berg, D., Gasser, T., Chen, H., Yao, C. W., Postuma, R. B., & the MDS Task Force on the Definition of Parkinson's Disease (2019) · Movement Disorders · doi:10.1002/mds.27802 · Cited by 779 · see citing works

Zinc in the physiology and pathology of the CNS

Sensi, S. L., Paoletti, P., Bush, A. I., & Sekler, I. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2734 · Cited by 759 · see citing works

The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration

Mahul-Mellier, A.-L., Burtscher, J., Maharjan, N., Weerens, L., Croisier, M., Kuttler, F., Leleu, M., Knott, G. W., & Lashuel, H. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913904117 · Cited by 710 · see citing works

ZnT-3, a putative transporter of zinc into synaptic vesicles

Palmiter, R. D., Cole, T. B., Quaife, C. J., & Findley, S. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14934 · Cited by 708 · see citing works

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698 · see citing works

Dementia associated with Parkinson's disease

Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 686 · see citing works

High-Affinity Zinc Inhibition of NMDA NR1–NR2A Receptors

Paoletti, P., Ascher, P., & Neyton, J. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05711.1997 · Cited by 650 · see citing works

Alpha‐synuclein <scp>RT</scp> ‐Qu <scp>IC</scp> in the <scp>CSF</scp> of patients with alpha‐synucleinopathies

Fairfoul, G., McGuire, L. I., Pal, S., Ironside, J. W., Neumann, J., Christie, S., Joachim, C., Esiri, M., Evetts, S. G., Rolinski, M., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.338 · Cited by 608 · see citing works

Modified hippocampal long-term potentiation in PKCγ-mutant mice

Abeliovich, A., Chen, C., Goda, Y., Silva, A. J., Stevens, C. F., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)90613-u · Cited by 524 · see citing works

EFNS / MDS ‐ ES recommendations for the diagnosis of P arkinson's disease

Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D. J., Burn, D. J., Colosimo, C., Fanciulli, A., et al. (2012) · European Journal of Neurology · doi:10.1111/ene.12022 · Cited by 491 · see citing works

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid

Shahnawaz, M., Tokuda, T., Waragai, M., Méndez, N., Ishii, R., Trenkwalder, C., Mollenhauer, B., & Soto, C. A. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4547 · Cited by 485 · see citing works

Synaptic clustering of AMPA receptors by the extracellular immediate-early gene product narp.

O’Brien, R. J., Xu, D., Petralia, R. S., Steward, O., Huganir, R. L., & Worley, P. (1999) · Neuron · doi:10.1016/s0896-6273(00)80782-5 · Cited by 471 · see citing works

β-Synuclein Inhibits α-Synuclein Aggregation

Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., & Masliah, E. (2001) · Neuron · doi:10.1016/s0896-6273(01)00462-7 · Cited by 398 · see citing works

Proposed neuropathological criteria for the <i>post mortem</i> diagnosis of multiple system atrophy

Trojanowski, J. Q., Revesz, T., & the Neuropathology Working Group on MSA (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00907.x · Cited by 349 · see citing works

The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease

Pissadaki, E. K., & Bolam, J. P. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00013 · Cited by 349 · see citing works

Neuropathological spectrum of synucleinopathies

Jellinger, K. A. (2003) · Movement Disorders · doi:10.1002/mds.10557 · Cited by 338 · see citing works

C-terminal calcium binding of α-synuclein modulates synaptic vesicle interaction

Lautenschläger, J., Stephens, A. D., Fusco, G., Ströhl, F., Curry, N., Zacharopoulou, M., Michel, C. H., Laine, R. F., Nespovitaya, N., Fantham, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03111-4 · Cited by 335 · see citing works

Copper(II)-induced self-oligomerization of α-synuclein

Paik, S. R., Shin, H.-J., Lee, J., Chang, C., & Kim, J. (1999) · Biochemical Journal · doi:10.1042/bj3400821 · Cited by 332 · see citing works

Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity

Tsui, C., Copeland, N., Gilbert, D., Jenkins, N., Barnes, C., & Worley, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-08-02463.1996 · Cited by 315 · see citing works

Concomitant loss of dynorphin, NARP, and orexin in narcolepsy

Crocker, A., España, R. A., Papadopoulou, M., Saper, C. B., Faraco, J., Sakurai, T., Honda, M., Mignot, E., & Scammell, T. E. (2005) · Neurology · doi:10.1212/01.wnl.0000168173.71940.ab · Cited by 301 · see citing works

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson’s disease

Garcia-Reitboeck, P., Anichtchik, O. V., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., Ghetti, B. F., Corte, L., Spano, P., Tofaris, G. K., et al. (2010) · Brain · doi:10.1093/brain/awq132 · Cited by 293 · see citing works

Narp and NP1 Form Heterocomplexes that Function in Developmental and Activity-Dependent Synaptic Plasticity

Xu, D., Hopf, C., Reddy, R., Cho, R. W., Guo, L., Lanahan, A., Petralia, R. S., Wenthold, R. J., O'Brien, R. J., & Worley, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00463-x · Cited by 265 · see citing works

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

Magdalinou, N. K., Paterson, R. W., Schott, J. M., Fox, N. C., Mummery, C. J., Blennow, K., Bhatia, K. P., Morris, H. R., Giunti, P., Warner, T. T., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309562 · Cited by 250 · see citing works

Molecular Mechanisms, Biological Actions, and Neuropharmacology of the Growth-Associated Protein GAP-43

Denny, J. B. (2006) · Current Neuropharmacology · doi:10.2174/157015906778520782 · Cited by 244 · see citing works

CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

Sjögren, M. J. C., Minthon, L., Davidsson, P., Granérus, A., Clarberg, A., Vanderstichele, H., Vanmechelen, E., Wallin, A., & Blennow, K. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070079 · Cited by 237 · see citing works

Increased CSF neurogranin concentration is specific to Alzheimer disease

Wellington, H., Paterson, R. W., Portelius, E., Törnqvist, U., Magdalinou, N., Fox, N. C., Blennow, K., Schott, J. M., & Zetterberg, H. (2016) · Neurology · doi:10.1212/wnl.0000000000002423 · Cited by 232 · see citing works

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease

George, S., Rey, N. L., Tyson, T., Esquibel, C., Meyerdirk, L., Schulz, E., Pierce, S., Burmeister, A. R., Madaj, Z., Steiner, J. A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0335-3 · Cited by 229 · see citing works

Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?

Bisaglia, M., & Bubacco, L. (2020) · Biomolecules · doi:10.3390/biom10020195 · Cited by 226 · see citing works

Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis

Eusebi, P., Giannandrea, D., Biscetti, L., Abraha, I., Chiasserini, D., Orso, M., Calabresi, P., & Parnetti, L. (2017) · Movement Disorders · doi:10.1002/mds.27110 · Cited by 222 · see citing works

Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach

Bereczki, E., Branca, R. M., Francis, P. T., Pereira, J. B., Baek, J.-H., Hortobágyi, T., Winblad, B., Ballard, C., Lehtiö, J., & Aarsland, D. (2018) · Brain · doi:10.1093/brain/awx352 · Cited by 220 · see citing works

Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression.

Berglund, E., Murai, K., Fredette, B., Sekerkovâ, G., Marturano, B., Weber, L., Mugnaini, E., & Ranscht, B. (1999) · Neuron · doi:10.1016/s0896-6273(00)81126-5 · Cited by 216 · see citing works

Modulation of Actin Filament Behavior by GAP-43 (Neuromodulin) Is Dependent on the Phosphorylation Status of Serine 41, the Protein Kinase C Site

He, Q., Dent, E. W., & Meiri, K. F. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03515.1997 · Cited by 216 · see citing works

α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies

Prots, I., Grosch, J., Brazdis, R.-M., Simmnacher, K., Veber, V., Havlicek, S., Hannappel, C., Krach, F., Krumbiegel, M., Schütz, O., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713129115 · Cited by 213 · see citing works

Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis

Gao, L., Tang, H., Nie, K., Wang, L., Zhao, J., Gan, R., Huang, J., Zhu, R., Feng, S., Duan, Z., et al. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.961454 · Cited by 204 · see citing works

Review: Parkinson's disease: from synaptic loss to connectome dysfunction

Bellucci, A., Mercuri, N. B., Venneri, A., Faustini, G., Longhena, F., Pizzi, M., Missale, C., & Spano, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12297 · Cited by 203 · see citing works

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

Bäckström, D. C., Domellöf, M. E., Linder, J., Olsson, B., Öhrfelt, A., Trupp, M., Zetterberg, H., Blennow, K., & Forsgren, L. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1449 · Cited by 197 · see citing works

A Shift from a Pivotal to Supporting Role for the Growth-Associated Protein (GAP-43) in the Coordination of Axonal Structural and Functional Plasticity

Holahan, M. R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00266 · Cited by 197 · see citing works

SNAP-25 Palmitoylation and Plasma Membrane Targeting Require a Functional Secretory Pathway

Gonzalo, S., & Linder, M. E. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.3.585 · Cited by 196 · see citing works

Elevated CSF GAP‐43 is Alzheimer's disease specific and associated with tau and amyloid pathology

Sandelius, Å., Portelius, E., Källén, Å., Zetterberg, H., Rot, U., Olsson, B., Toledo, J. B., Shaw, L. M. J., Lee, V. M. ‐., Irwin, D. J., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.08.006 · Cited by 191 · see citing works

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Poggiolini, I., Gupta, V., Lawton, M., Lee, S., El-Turabi, A., Querejeta-Coma, A., Trenkwalder, C., Sixel-Döring, F., Foubert-Samier, A., Pavy-Le Traon, A., et al. (2022) · Brain · doi:10.1093/brain/awab431 · Cited by 191 · see citing works

How to diagnose dementia with Lewy bodies: State of the art

Geser, F., Wenning, G. K., Poewe, W. H., & McKeith, I. G. (2005) · Movement Disorders · doi:10.1002/mds.20535 · Cited by 184 · see citing works

Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study

Miki, Y., Foti, S. C., Asi, Y. T., Tsushima, E., Quinn, N. P., Ling, H., & Holton, J. L. (2019) · Brain · doi:10.1093/brain/awz189 · Cited by 181 · see citing works

Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging

Matuskey, D., Tinaz, S., Wilcox, K. C., Naganawa, M., Toyonaga, T., Dias, M., Henry, S. E., Pittman, B. P., Ropchan, J. R., Nabulsi, N., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25682 · Cited by 180 · see citing works

Phosphorylation of B‐50 (GAP43) Is Correlated with Neurotransmitter Release in Rat Hippocampal Slices

Dekker, L. V., Graan, P. N. E. D., Versteeg, D. H. G., et al. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10893.x · Cited by 179 · see citing works

Cerebrospinal fluid neurogranin and <scp>YKL</scp> ‐40 as biomarkers of Alzheimer's disease

Janelidze, S., Hertze, J., Zetterberg, H., Landqvist Waldö, M., Santillo, A., Blennow, K., & Hansson, O. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.266 · Cited by 179 · see citing works

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

Parnetti, L., Farotti, L., Eusebi, P., Chiasserini, D., Carlo, C. D., Giannandrea, D., Salvadori, N., Lisetti, V., Tambasco, N., Rossi, A., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00053 · Cited by 177 · see citing works

α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease

Sorrentino, Z. A., Giasson, B. I., & Chakrabarty, P. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01977-2 · Cited by 177 · see citing works

Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease

Beckmann, N. D., Lin, W.-J., Wang, M., Cohain, A. T., Charney, A. W., Wang, P., Ma, W., Wang, Y.-C., Jiang, C., Audrain, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17405-z · Cited by 172 · see citing works

Synaptic failure and α‐synuclein

Calò, L., Węgrzynowicz, M., Santivañez‐Perez, J., & Spillantini, M. G. (2016) · Movement Disorders · doi:10.1002/mds.26479 · Cited by 170 · see citing works

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia

Bereczki, E., Francis, P. T., Howlett, D., Pereira, J. B., Höglund, K., Bogstedt, A., Cedazo‐Minguez, A., Baek, J., Hortobágyi, T., Attems, J., et al. (2016) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2016.04.005 · Cited by 167 · see citing works

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

Portelius, E., Olsson, B., Höglund, K., Cullen, N. C., Kvartsberg, H., Andréasson, U., Zetterberg, H., Sandelius, Å., Shaw, L. M. J., Lee, V. M. ‐., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1851-x · Cited by 167 · see citing works

Multiple system atrophy: a clinical and neuropathological perspective

Ubhi, K. K., Low, P. A., & Masliah, E. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.08.003 · Cited by 159 · see citing works

Roles of Glutamate Receptors in Parkinson’s Disease

Zhang, Z., Zhang, S., Fu, P., Zhang, Z., Lin, K., Ko, J. K.-S., & Yung, K. K. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184391 · Cited by 159 · see citing works

C‐terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

Vos, A. D., Jacobs, D., Struyfs, H., Fransén, E., Andersson, K., Portelius, E., Andréasson, U., Surgeloose, D. D., Hernalsteen, D., Sleegers, K., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.05.012 · Cited by 158 · see citing works

α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies

Bongianni, M., Ladogana, A., Capaldi, S., Klotz, S., Baiardi, S., Cagnin, A., Perra, D., Fiorini, M., Poleggi, A., Legname, G., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50897 · Cited by 155 · see citing works

Activity-Regulated N-Cadherin Endocytosis

Tai, C., Mysore, S. P., Chiu, C., & Schuman, E. M. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.013 · Cited by 153 · see citing works

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls

Mollenhauer, B., Caspell‐Garcia, C., Coffey, C. S., Taylor, P., Shaw, L. M. J., Trojanowski, J. Q., Singleton, A. B., Frasier, M. A., Marek, K., Galasko, D. R., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004609 · Cited by 153 · see citing works

Monitoring of 30 marker candidates in early Parkinson disease as progression markers

Mollenhauer, B., Zimmermann, J., Sixel‐Döring, F., Focke, N. K., Wicke, T., Ebentheuer, J., Schaumburg, M., Lang, E., Trautmann, E., Zetterberg, H., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002651 · Cited by 151 · see citing works

Biochemical Interactions of the Neuronal Pentraxins

Kirkpatrick, L., Matzuk, M. M., Dodds, D. C., & Perin, M. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002254200 · Cited by 149 · see citing works

Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses

Lee, S.-J., Wei, M., Zhang, C., Maxeiner, S., Pak, C., Calado Botelho, S., Trotter, J., Sterky, F. H., & Südhof, T. C. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2768-16.2016 · Cited by 146 · see citing works

Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy

Wennström, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., Boström, F., Hansson, O., & Nielsen, H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053250 · Cited by 141 · see citing works

Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer′s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies

Oeckl, P., Metzger, F., Nagl, M., Arnim, C. A. F. V., Halbgebauer, S., Steinacker, P., Ludolph, A. C., & Otto, M. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.059915 · Cited by 135 · see citing works

Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes

Quadalti, C., Buonaura, G. C., Baiardi, S., Mastrangelo, A., Rossi, M., Zenesini, C., Giannini, G., Candelise, N., Sambati, L., Polischi, B., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00232-4 · Cited by 133 · see citing works

Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies

Brockmann, K., Quadalti, C., Lerche, S., Rossi, M., Wurster, I., Baiardi, S., Röeben, B., Mammana, A., Zimmermann, M., Hauser, A., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01276-6 · Cited by 132 · see citing works

Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies

Singer, W., Schmeichel, A. M., Shahnawaz, M., Schmelzer, J. D., Boeve, B. F., Sletten, D. M., Gehrking, T. L., Gehrking, J. A., Olson, A. D., Savica, R., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25824 · Cited by 131 · see citing works

Brain region‐dependent differential expression of alpha‐synuclein

Taguchi, K., Watanabe, Y., Tsujimura, A., & Tanaka, M. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23901 · Cited by 124 · see citing works

fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies

Peraza, L. R., Kaiser, M., Firbank, M., Graziadio, S., Bonanni, L., ONOFRJ, M. C., Colloby, S. J., Blamire, A. M., O'Brien, J. T., & Taylor, J. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.03.013 · Cited by 121 · see citing works

Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration

Durante, V., de Iure, A., Loffredo, V., Vaikath, N. N., Risi, M. D., Paciotti, S., Quiroga‐Varela, A., Chiasserini, D., Mellone, M., Mazzocchetti, P., et al. (2019) · Brain · doi:10.1093/brain/awz065 · Cited by 117 · see citing works

Angiotensinogen Gene and Blood Pressure in the Japanese Population

Iwai, N., Shimoike, H., Ohmichi, N., et al. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.688 · Cited by 113 · see citing works

α-Synuclein and Its A30P Mutant Affect Actin Cytoskeletal Structure and Dynamics

Sousa, V. L., Bellani, S., Giannandrea, M., Yousuf, M., Valtorta, F., Meldolesi, J., & Chieregatti, E. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-03-0302 · Cited by 112 · see citing works

Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson’s disease

Olanow, C. W., Savolainen, M., Chu, Y., Halliday, G. M., & Kordower, J. H. (2019) · Brain · doi:10.1093/brain/awz104 · Cited by 112 · see citing works

Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies

Rossi, M., Baiardi, S., Teunissen, C. E., Quadalti, C., Beek, M. H. C. T. V., Mammana, A., Maserati, M. S., van der Flier, W. M., Sambati, L., Zenesini, C., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012438 · Cited by 111 · see citing works

Oligomeric α-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease

Agliardi, C., Meloni, M., Guerini, F. R., Zanzottera, M., Bolognesi, E., Baglio, F., & Clerici, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105185 · Cited by 106 · see citing works

Alpha-synuclein activates BV2 microglia dependent on its aggregation state

Hoffmann, A., Ettle, B., Bruno, A., Kulinich, A. O., Hoffmann, A.-C., von Wittgenstein, J., Winkler, J., Xiang, W., & Schlachetzki, J. C. M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.109 · Cited by 105 · see citing works

α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

van Steenoven, I., Majbour, N. K., Vaikath, N. N., Berendse, H. W., van der Flier, W. M., van de Berg, W. D. J., Teunissen, C. E., Lemstra, A. W., & El‐Agnaf, O. M. A. (2018) · Movement Disorders · doi:10.1002/mds.111 · Cited by 103 · see citing works

Endogenous Zinc Inhibits GABAAReceptors in a Hippocampal Pathway

Ruiz, A. J., Walker, M. C., Fabian‐Fine, R., & Kullmann, D. M. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00755.2003 · Cited by 100 · see citing works

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease

Remnestål, J., Just, D., Mitsios, N., Fredolini, C., Mulder, J., Schwenk, J. M., Uhlén, M., Kultima, K., Ingelsson, M., Kilander, L., et al. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500150 · Cited by 97 · see citing works

Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease

Delva, A., Weehaeghe, D. V., Koole, M. J. B., Laere, K. V., & Vandenberghe, W. (2020) · Movement Disorders · doi:10.1002/mds.28216 · Cited by 97 · see citing works

Resting-state fMRI study on drug-naive patients with Parkinson's disease and with depression

Luo, C., Chen, Q., Song, W., Chen, K., Guo, X., Yang, J., Huang, X., Gong, Q., & Shang, H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306237 · Cited by 92 · see citing works

α-Synuclein may cross-bridge v-SNARE and acidic phospholipids to facilitate SNARE-dependent vesicle docking

Lou, X., Kim, J., Hawk, B. J. D., & Shin, Y. (2017) · Biochemical Journal · doi:10.1042/bcj20170200 · Cited by 91 · see citing works

Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer’s Disease

Oeckl, P., Halbgebauer, S., Anderl‐Straub, S., Arnim, C. A. F. V., Diehl‐Schmid, J., Froelich, L., Grimmer, T., Hausner, L., Denk, J., Jahn, H., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00824 · Cited by 91 · see citing works

Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ <scp> ¹¹ C </scp> ] <scp>UCB‐J PET</scp> Imaging Study

Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjærbæk, C., Gottrup, H., Klit, H., Schacht, A. C., Danielsen, E. H., Brooks, D. J., et al. (2021) · Movement Disorders · doi:10.1002/mds.28617 · Cited by 84 · see citing works

Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations

Khundakar, A. A., Hanson, P. S., Erskine, D., Lax, N. Z., Roscamp, J., Karyka, E., Tsefou, E., Singh, P., Cockell, S., Gribben, A., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0334-3 · Cited by 83 · see citing works

The Temperature-Dependent Retention of Introns in GPI8 Transcripts Contributes to a Drooping and Fragile Shoot Phenotype in Rice

Zhao, B., Tang, Y., Zhang, B., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010299 · Cited by 83 · see citing works

Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach

van Steenoven, I., Koel-Simmelink, M. J. A., Vergouw, L. J. M., Tijms, B. M., Piersma, S. R., Pham, T. V., Bridel, C., Ferri, G.-L., Cocco, C., Noli, B., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00388-2 · Cited by 83 · see citing works

Distribution of VGF peptides in the human cortex and their selective changes in Parkinson’s and Alzheimer’s diseases

Cocco, C., D’Amato, F., Noli, B., Ledda, A., Brancia, C., Bongioanni, P., & Ferri, G. (2010) · Journal of Anatomy · doi:10.1111/j.1469-7580.2010.01309.x · Cited by 75 · see citing works

Synaptic proteins in CSF relate to Parkinson’s disease stage markers

Bereczki, E., Bogstedt, A., Höglund, K., Tsitsi, P., Brodin, L., Ballard, C., Svenningsson, P., & Aarsland, D. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-017-0008-2 · Cited by 72 · see citing works

Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks

Lowther, E. R., O'Brien, J. T., Firbank, M., & Blamire, A. M. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.06.004 · Cited by 71 · see citing works

Synaptic Zinc: An Emerging Player in Parkinson’s Disease

Sikora, J., & Ouagazzal, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094724 · Cited by 71 · see citing works

Reduced alpha‐synuclein in cerebrospinal fluid in synucleinopathies: Evidence from a meta‐analysis

Sako, W., Murakami, N., Izumi, Y., et al. (2014) · Movement Disorders · doi:10.1002/mds.26036 · Cited by 70 · see citing works

Neuronal pentraxin II is highly upregulated in Parkinson’s disease and a novel component of Lewy bodies

Moran, L. B., Hickey, L., Michael, G. J., Derkacs, M., Christian, L. M., Kalaitzakis, M. E., Pearce, R. K. B., & Graeber, M. B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0309-3 · Cited by 69 · see citing works

Differential dynamics and activity-dependent regulation of α- and β-neurexins at developing GABAergic synapses

Fu, Y., & Huang, Z. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011233108 · Cited by 68 · see citing works

Relevance of presynaptic actin dynamics for synapse function and mouse behavior

Rust, M. B., & Maritzen, T. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.12.020 · Cited by 66 · see citing works

Prodynorphin storage and processing in axon terminals and dendrites

Yakovleva, T., Bazov, I., Cebers, G., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6174fje · Cited by 66 · see citing works

The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluidα-Synuclein Levels in Parkinson’s Disease: A Meta-Analysis

Zhou, B., Wen, M., Yu, W., Zhang, C., & Jiao, L. (2015) · Parkinson s Disease · doi:10.1155/2015/567386 · Cited by 65 · see citing works

Inhibitory zinc-enriched terminals in the mouse cerebellum: double-immunohistochemistry for zinc transporter 3 and glutamate decarboxylase

Wang, Z., Danscher, G., Kim, Y. K., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02560-5 · Cited by 64 · see citing works

Order and disorder in the physiological membrane binding of α-synuclein

Fusco, G., Sanz-Hernández, M., & Simone, A. D. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.09.004 · Cited by 64 · see citing works

Parkinson’s disease dementia: Diagnostic criteria and risk factor review

Vasconcellos, L. F., & Pereira, J. S. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1073227 · Cited by 61 · see citing works

Identifying Dynamic Functional Connectivity Changes in Dementia with Lewy Bodies Based on Product Hidden Markov Models

Sourty, M., Thoraval, L., Roquet, D., Armspach, J., Foucher, J., & Blanc, F. (2016) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2016.00060 · Cited by 60 · see citing works

Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer’s disease

Halbgebauer, S., Oeckl, P., Steinacker, P., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324306 · Cited by 60 · see citing works

Neural circuit formation in the cerebellum is controlled by cell adhesion molecules of the Contactin family

Stoeckli, E. T. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.4.12733 · Cited by 55 · see citing works

SNARE Regulatory Proteins in Synaptic Vesicle Fusion and Recycling

Sauvola, C. W., & Littleton, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.733138 · Cited by 53 · see citing works

Dependence of the histofluorescently reactive zinc pool on zinc transporter-3 in the normal brain

Lee, J. Y., Kim, J. S., Byun, H.-R., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.055 · Cited by 52 · see citing works

Dynamic Control of Synaptic Adhesion and Organizing Molecules in Synaptic Plasticity

Rudenko, G. (2017) · Neural Plasticity · doi:10.1155/2017/6526151 · Cited by 52 · see citing works

Lack of vesicular zinc in mossy fibers does not affect synaptic excitability of CA3 pyramidal cells in zinc transporter 3 knockout mice

Lopantsev, V., Wenzel, H. J., Cole, T. B., Palmiter, R. D., & Schwartzkroin, P. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00570-5 · Cited by 51 · see citing works

F3/Contactin promotes hippocampal neurogenesis, synaptic plasticity, and memory in adult mice

Puzzo, D., Bizzoca, A., Privitera, L., Furnari, D., Giunta, S., Girolamo, F., Pinto, M. F., Gennarini, G., & Palmeri, A. (2013) · Hippocampus · doi:10.1002/hipo.22186 · Cited by 51 · see citing works

Alterations in peptide levels in Parkinson's disease and incidental Lewy body disease

Fernandez, A., CEBALLOS, M. L. D., Rose, S., et al. (1996) · Brain · doi:10.1093/brain/119.3.823 · Cited by 50 · see citing works

Cadherin-Based Transsynaptic Networks in Establishing and Modifying Neural Connectivity

Friedman, L. G., Benson, D. L., & Huntley, G. W. (2015) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2014.11.025 · Cited by 47 · see citing works

Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults

Soldan, A., Moghekar, A., Walker, K. A., Pettigrew, C. A., Hou, X., Lu, H., Miller, M. I., Alfini, A. J., Albert, M., Xu, D., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00132 · Cited by 46 · see citing works

Real‐time imaging of plasma membrane deformations reveals pre‐fusion membrane curvature changes and a role for dynamin in the regulation of fusion pore expansion

Anantharam, A., Axelrod, D., & Holz, R. W. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07816.x · Cited by 42 · see citing works

VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies

van Steenoven, I., Noli, B., Cocco, C., Ferri, G., Oeckl, P., Otto, M., Koel‐Simmelink, M. J. A., Bridel, C., van der Flier, W. M., Lemstra, A. W., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194674 · Cited by 42 · see citing works

Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF

Boiten, W., van Steenoven, I., Xiao, M.-F., Worley, P., Noli, B., Cocco, C., Ferri, G.-L., Lemstra, A., & Teunissen, C. (2020) · Cells · doi:10.3390/cells10010038 · Cited by 42 · see citing works

The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies

Beyer, K., Domingo-Sàbat, M., dos Santos, C. M. P., TOLOSA, E. S., Ferrer, I., & Ariza, A. (2010) · Brain · doi:10.1093/brain/awq275 · Cited by 41 · see citing works

Abundance of Synaptic Vesicle-Related Proteins in Alpha-Synuclein-Containing Protein Inclusions Suggests a Targeted Formation Mechanism

McCormack, A., Keating, D. J., Chegeni, N., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00014-0 · Cited by 37 · see citing works

Cerebrospinal Fluid Levels of Neurogranin in Parkinsonian Disorders

Hall, S., Janelidze, S., Zetterberg, H., Brix, B., Mattsson, N., Surova, Y., Blennow, K., & Hansson, O. (2019) · Movement Disorders · doi:10.1002/mds.27950 · Cited by 36 · see citing works

Synaptic adhesion molecule OBCAM; synaptogenesis and dynamic internalization

Yamada, M., Hashimoto, T., Hayashi, N., Higuchi, M., Murakami, A., Nakashima, T., Maékawa, S., & Miyata, S. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.062 · Cited by 34 · see citing works

Dynamin−SNARE interactions control trans-SNARE formation in intracellular membrane fusion

Alpadi, K., Kulkarni, A., Namjoshi, S., et al. (2013) · Nature Communications · doi:10.1038/ncomms2724 · Cited by 33 · see citing works

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease

Chatterjee, M., del Campo, M., Morrema, T. H. J., de Waal, M. W. J., van der Flier, W. M., Hoozemans, J. J. M., & Teunissen, C. E. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0383-x · Cited by 33 · see citing works

Impaired synaptic function is linked to cognition in Parkinson's disease

Selnes, P., Stav, A. L., Johansen, K. K., Bjørnerud, A., Coello, C. S., Auning, E., Kalheim, L. F., Almdahl, I. S., Hessen, E., Zetterberg, H., et al. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.446 · Cited by 31 · see citing works

Mobilization of the cell adhesion glycoprotein F3/contactin to axonal surfaces is activity dependent

Pierre, K., Dupouy, B., Michèle Allard, A., Poulain, D. A., & Theodosis, D. T. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01682.x · Cited by 30 · see citing works

11C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies

Nicastro, N., Holland, N., Savulich, G., Carter, S. F., Mak, E., Hong, Y. T., Milicevic Sephton, S., Fryer, T. D., Aigbirhio, F. I., Rowe, J. B., et al. (2020) · European Journal of Hybrid Imaging · doi:10.1186/s41824-020-00093-9 · Cited by 28 · see citing works

Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson’s disease

Koob, A. O., Shaked, G. M., Bender, A., Bisquertt, A., Rockenstein, E. M., & Masliah, E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.013 · Cited by 25 · see citing works

Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia

Vallortigara, J., Rangarajan, S., Whitfield, D., Alghamdi, A. A., Howlett, D. R., Hortobágyi, T., Johnson, M. A., Attems, J., Ballard, C. G., Thomas, A. J., et al. (2014) · F1000Research · doi:10.12688/f1000research.3786.1 · Cited by 25 · see citing works

Contactin-1 Is Reduced in Cerebrospinal Fluid of Parkinson’s Disease Patients and Is Present within Lewy Bodies

Chatterjee, M., van Steenoven, I., Huisman, E., Oosterveld, L. P., Berendse, H. W., van der Flier, W. M., del Campo, M., Lemstra, A. W., van de Berg, W. D. J., & Teunissen, C. E. (2020) · Biomolecules · doi:10.3390/biom10081177 · Cited by 25 · see citing works

β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins

Ninkina, N. N., Millership, S. J., Peters, O. M., Connor‐Robson, N., Chaprov, K., Kopylov, A. T., Montoya, A., Kramer, H., Withers, D. J., & Buchman, V. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101375 · Cited by 25 · see citing works

Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility

Sevlever, D., Zou, F., Ma, L., Carrasquillo, S., Crump, M., Culley, O. J., Hunter, T. A., Bisceglio, G. D., Younkin, L. H., Allen, M., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0015-x · Cited by 22 · see citing works

Increased Cerebrospinal Fluid Concentration of ZnT3 Is Associated with Cognitive Impairment in Alzheimer’s Disease

Enache, D., Pereira, J. B., Jelić, V., Winblad, B. G., Nilsson, P., Aarsland, D., & Bereczki, E. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200498 · Cited by 21 · see citing works

Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons

Jeannotte, A. M., & Sidhu, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05258.x · Cited by 16 · see citing works

Neuromolecular imaging, a nanobiotechnology for Parkinson’s disease: advancing pharmacotherapy for personalized medicine

Broderick, P. A., Wenning, L., & Li, Y.-S. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1633-3 · Cited by 16 · see citing works

Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease

Wallin, A., Jennersjö, C., & Granérus, A. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00018-8 · Cited by 11 · see citing works

Kinetic Study on the Reactivity of Azanone (HNO) toward Cyclic C-Nucleophiles

Artelska, A., Rola, M., Rostkowski, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312982 · Cited by 9 · see citing works

Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia

Das, S., Goossens, J., Jacobs, D., Dewit, N., Pijnenburg, Y. A. L., In ‘t Veld, S. G. J. G., Teunissen, C. E., & Vanmechelen, E. (2023) · Alzheimer's Research &amp; Therapy · doi:10.1186/s13195-023-01212-x · Cited by 50 · see citing works

GBA1 Gene Mutations in α-Synucleinopathies—Molecular Mechanisms Underlying Pathology and Their Clinical Significance

Granek, Z., Barczuk, J., Siwecka, N., Rozpędek‐Kamińska, W., Kucharska, E., & Majsterek, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032044 · Cited by 47 · see citing works

The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies

Van der Perren, A., Gelders, G., Fenyi, A., Bousset, L., Brito, F., Peelaerts, W., Van den Haute, C., Gentleman, S., Melki, R., & Baekelandt, V. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02157-3 · Cited by 277 · see citing works

Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies

Rossi, M., Candelise, N., Baiardi, S., Capellari, S., Giannini, G., Orru, C. D., Antelmi, E., Mammana, A., Hughson, A. G., Buonaura, G. C., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02160-8 · Cited by 457 · see citing works

α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies

Bongianni, M., Ladogana, A., Capaldi, S., Klotz, S., Baiardi, S., Cagnin, A., Perra, D., Fiorini, M., Poleggi, A., Legname, G., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50897 · Cited by 155 · see citing works

Lewy Body Dementias and Other Synucleinopathies

Stahl, S. M., & Morrissette, D. A. (2018) · doi:10.1017/9781107706842.005